🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study employs a multicenter, randomized, open-label, positive drug-con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06854276
The purpose of this study is to determine whether recombinant human Erythro...
Status
Completed
Location
Clinic of Movement Disorders, International Center for Neurological Restoration
Start Date
2008-08
Trial ID
NCT01010802
Treatments Being Tested
A recent study by Plenge et al. revealed that rhEpo treatment enhances skel...
Status
Completed
Location
Copenhagen University Hospital Bispebjerg, Department of Anaesthesiology
Start Date
2011-09
Trial ID
NCT03093506
Treatments Being Tested
Daprodustat administration has the potential, by virtue of increasing hypox...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-07-30
Trial ID
NCT03457701
Periventricular leukomalacia (PVL) is one of the most common brain injuries...
Status
Unknown
Location
China Medical University Hospital
Start Date
2009-08
Trial ID
NCT00910234
In the ELGAN (Extremely Low Gestational Age Newborn) study, abnormal brain ...
Status
Unknown
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02745990
Treatments Being Tested
The purpose of this multi-center study in non-dialysis participants with an...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-03-05
Trial ID
NCT03409107
Treatments Being Tested
This study is intended to evaluate the dose-response relationship of GSK127...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-01
Trial ID
NCT01977482
Treatments Being Tested
The administration of rhEPO on the one day before cardiac surgery will be e...
Status
Completed
Location
Severance hospital
Start Date
2009-04
Trial ID
NCT00939978
Treatments Being Tested
The study will evaluate the ability of GSK1278863 to increase the hemoglobi...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-06-11
Trial ID
NCT02075463
Treatments Being Tested